Previous studies have indicated that mutations in TNIP1 are associated with psoriasis (35), rheumatoid arthritis (36), systemic lupus erythematosus (37), and leukemia and lymphoma (38, 39). This evidence concerns the gene TNIP1 and lymphoma.